6LL-22416-74615
4 vaccinations
3 coded responses
45 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 800 / CO
- Registered
- 2021-04-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
B23-29619-45701
Child or adolescent in my care · Male · 2022-06-21
HWN-12472-08056
Child or adolescent in my care · Female · 2022-06-21
Timeline
-
2021-04-05
Dose 1 — Pfizer-BioNTech
-
2021-04-21
Registered in v-safe
- 2021-04-21
- 2021-04-26
-
2021-05-03
Dose 2 — Pfizer-BioNTech
- 2021-05-03
-
2021-05-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-05
Survey response — days 1–6 daily, dose 2MedDRA: Injection site bruising — Feeling: GoodFree text: Bruising at injection site.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-06
- 2021-05-07
- 2021-05-08
- 2021-05-09
- 2021-05-10
- 2021-05-17
- 2021-05-24
- 2021-05-31
- 2021-06-07
- 2021-06-14
- 2021-08-02
- 2021-11-01
-
2021-11-24
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-11-24
- 2021-11-25
- 2021-11-26
- 2021-11-27
- 2021-11-28
- 2021-11-29
- 2021-11-30
- 2021-12-01
- 2021-12-08
- 2021-12-15
- 2021-12-29
- 2022-01-07
- 2022-02-23
- 2022-05-25
-
2022-09-23
Dose 4 — Pfizer-BioNTech
- 2022-09-23
-
2022-09-24
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2022-09-25
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2022-09-26
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-09-27
- 2022-09-28
- 2022-10-04
-
2022-10-07
Survey response — day 14, dose 4MedDRA: Oropharyngeal pain, Rhinorrhoea — Feeling: GoodFree text: Sore throat, runny nose.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-14
Survey response — day 21, dose 4MedDRA: Cough, Oropharyngeal pain, Pyrexia, Rhinorrhoea — Feeling: Good · Be unable to do your normal daily activitiesFree text: Cough, runny nose, sore throat, feverMedDRA releases: 2024-11 · check-in free text available
- 2022-10-21
- 2022-10-28
- 2022-11-04
- 2022-12-23
- 2023-03-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-05 | Pfizer-BioNTech | |
| 2 | 2021-05-03 | Pfizer-BioNTech | |
| 3 | 2021-11-24 | Pfizer-BioNTech | Flu |
| 4 | 2022-09-23 | Pfizer-BioNTech | No |
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Bruising at injection site.
Release 12 — day 14, dose 4
Symptoms: Sore throat, runny nose.
Release 12 — day 21, dose 4
Symptoms: Cough, runny nose, sore throat, fever
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release